SkinnyRx review
A flat $199/mo semaglutide, $299/mo tirzepatide, with an option most of this batch skips: a sublingual tablet instead of a weekly shot — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
SkinnyRx at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed on the public site we reviewed
- Brand-name
- Compounded only
How we scored SkinnyRx
Each score comes out of SkinnyRx's published pricing, disclosures and oversight, and the six combine into the 44/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- skinnyrx.com
$199 for the injectable, $249 for sublingual tablets, $299 for tirzepatide in either form — pulled from the site's own structured product data, since the page itself returns only a shell. No state list appears anywhere on the public site.
What to expect when you sign up
We walked SkinnyRx's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Structured product data lists one flat price per form (injectable or tablet) for each molecule
- 2Complete an online quiz-based intake
- 3A licensed provider reviews and prescribes if appropriate
- 4Medication ships if approved
What we noticed
- Offers a real choice most of this batch doesn't: sublingual tablets alongside the injectable, for both molecules
- Its own code carries an internal flag literally named "no_membership" next to its pricing data
- The site is a client-rendered app — pricing was pulled from the compiled JavaScript bundle's own product schema, not a plain page fetch
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
- The site itself makes no mention of its own FDA warning letter — that fact came from FDA.gov, not SkinnyRx's own copy
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Injectable |
| Oral semaglutide | $249 | Sublingual tablets |
| Compounded tirzepatide | $299 | Injectable |
| Oral tirzepatide | $299 | Sublingual tablets |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from SkinnyRx's public disclosures at last review and change often; confirm the current number on SkinnyRx's own site.
What we like
- Offers sublingual tablets as a genuine alternative to injections for both molecules
- Flat pricing regardless of dose
- Internal site code carries a "no_membership" flag consistent with no separate fee
The caveats
- No state list published anywhere on the public site
- Pricing only surfaces in compiled app data, not a plain page read
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
- The FDA issued its parent company, Lean Rx, Inc., an FDA warning letter dated 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing claims implying its compounded products share FDA-approved status with brand-name drugs like Mounjaro and Zepbound, which they don't — confirmed on FDA.gov, and never mentioned anywhere on SkinnyRx's own site
SkinnyRx for mothers: our verdict
A flat $199/mo semaglutide, $299/mo tirzepatide, with an option most of this batch skips: a sublingual tablet instead of a weekly shot — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it. It runs about $199/month, flat across every dose.
We weigh SkinnyRx the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What SkinnyRx actually costs
- Compounded semaglutide — Injectable: $199/mo
- Oral semaglutide — Sublingual tablets: $249/mo
- Compounded tirzepatide — Injectable: $299/mo
- Oral tirzepatide — Sublingual tablets: $299/mo
That's roughly in line with the ~$179/month median across our roster.
The medications SkinnyRx prescribes
SkinnyRx prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where SkinnyRx fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
SkinnyRx is a provider we list only with full disclosure — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers willing to verify SkinnyRx's compounding and ingredient claims for themselves rather than take its labels or marketing at face value — the FDA found the site misrepresents who actually compounds these products and implies an FDA-approved status they don't have. Read the FDA's letter before you weigh in the tablet option or the flat pricing.
Alternatives to SkinnyRx
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing SkinnyRx
Head-to-head & alternatives
SkinnyRx, answered
- Does SkinnyRx offer pills instead of a shot?
- Yes — sublingual tablets are available for both semaglutide ($249/mo) and tirzepatide ($299/mo), alongside the injectable forms ($199/mo and $299/mo).
- Is there a separate membership fee?
- Its own site code carries an internal flag named "no_membership" next to its pricing data, consistent with a flat price and nothing stacked on top — though this wasn't confirmed through a live checkout.
- Does SkinnyRx have an FDA warning letter?
- Yes — the FDA issued one dated 02/20/2026 (ref. 717989) to Lean Rx, Inc., SkinnyRx's legal entity, after reviewing skinnyrx.com in December 2025. It found the site's product labels falsely display "SkinnyRx" as the compounder of its semaglutide and tirzepatide products, and that marketing lines like "from the same family as GLP-1 treatments like Mounjaro and Zepbound" wrongly imply FDA-approved status for products that don't have it. We confirmed this directly on FDA.gov; SkinnyRx's own site makes no mention of it.
Pricing, states and verification reflect SkinnyRx's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.